[go: up one dir, main page]

NO180620C - Fremgangsmåte for fremstilling av surfaktantsuspensjoner for substitusjonsterapi ved luftveissykdommer - Google Patents

Fremgangsmåte for fremstilling av surfaktantsuspensjoner for substitusjonsterapi ved luftveissykdommer

Info

Publication number
NO180620C
NO180620C NO902961A NO902961A NO180620C NO 180620 C NO180620 C NO 180620C NO 902961 A NO902961 A NO 902961A NO 902961 A NO902961 A NO 902961A NO 180620 C NO180620 C NO 180620C
Authority
NO
Norway
Prior art keywords
preparation
respiratory diseases
surfactant
substitution therapy
suspensions
Prior art date
Application number
NO902961A
Other languages
English (en)
Other versions
NO902961L (no
NO180620B (no
NO902961D0 (no
Inventor
Bernd Disse
Eberhard Weller
Robert Becker
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NO902961D0 publication Critical patent/NO902961D0/no
Publication of NO902961L publication Critical patent/NO902961L/no
Publication of NO180620B publication Critical patent/NO180620B/no
Publication of NO180620C publication Critical patent/NO180620C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42Respiratory system, e.g. lungs, bronchi or lung cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785Alveolar surfactant peptides; Pulmonary surfactant peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Physiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Artificial Filaments (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO902961A 1989-07-04 1990-07-03 Fremgangsmåte for fremstilling av surfaktantsuspensjoner for substitusjonsterapi ved luftveissykdommer NO180620C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3921954A DE3921954A1 (de) 1989-07-04 1989-07-04 Niedrig-viskose, hochkonzentrierte surfactant-suspension

Publications (4)

Publication Number Publication Date
NO902961D0 NO902961D0 (no) 1990-07-03
NO902961L NO902961L (no) 1991-01-07
NO180620B NO180620B (no) 1997-02-10
NO180620C true NO180620C (no) 1997-05-21

Family

ID=6384269

Family Applications (1)

Application Number Title Priority Date Filing Date
NO902961A NO180620C (no) 1989-07-04 1990-07-03 Fremgangsmåte for fremstilling av surfaktantsuspensjoner for substitusjonsterapi ved luftveissykdommer

Country Status (24)

Country Link
US (1) US5552161A (no)
EP (1) EP0406732B1 (no)
JP (1) JP3103582B2 (no)
KR (1) KR0162642B1 (no)
AT (1) ATE122891T1 (no)
AU (1) AU623538B2 (no)
CA (1) CA2020209C (no)
DD (1) DD297916A5 (no)
DE (2) DE3921954A1 (no)
DK (1) DK0406732T3 (no)
ES (1) ES2072940T3 (no)
FI (1) FI95655C (no)
HK (1) HK1000277A1 (no)
HU (1) HU205004B (no)
IE (1) IE68448B1 (no)
IL (1) IL94961A (no)
NO (1) NO180620C (no)
NZ (2) NZ234341A (no)
PH (1) PH30232A (no)
PL (1) PL164434B1 (no)
PT (1) PT94574B (no)
RU (1) RU2077880C1 (no)
UA (1) UA26313A (no)
ZA (1) ZA905182B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4418936A1 (de) * 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
US6129934A (en) * 1995-06-07 2000-10-10 Ony, Inc. Modification of animal lung surfactant for treating respiratory disease due to lung surfactant deficiency or dysfunction
US6172203B1 (en) * 1996-02-07 2001-01-09 Alfredo Adolfo Hager Method for extracting and purifying pulmonary surfactant
CA2384861A1 (en) 1999-09-16 2001-03-22 Byk Gulden Lomberg Chemische Fabrik Gmbh Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
EP1249244A1 (en) 2001-04-13 2002-10-16 Universiteit Gent Therapeutic compositions for the treatment of a disease modulated by the G-actin / F-actin equilibrium, especially a respiratory tract disease
EP1435994B1 (de) 2001-10-11 2010-05-19 Nycomed GmbH Neue verwendung von lungensurfactant
US8337815B2 (en) * 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
EP1881323B1 (en) * 2005-05-11 2011-07-27 Yamasa Corporation Method of stabilizing pulmonary surfactant protein
US8048043B2 (en) * 2007-06-08 2011-11-01 Chiesi Farmaceutici S. P. A. Method of administration of a pulmonary surfactant

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55160721A (en) * 1979-06-02 1980-12-13 Tokyo Tanabe Co Ltd Pulmonary surfactant ta-546, its preparation, and remedy for pulmonary hyaline membrane syndrome comprising it as active constituent
EP0110498B2 (en) * 1982-11-22 1991-09-18 Teijin Limited Artificial lung surfactant and remedy for respiratory distress syndrome containing it as active principle
JPS59164724A (ja) * 1983-03-10 1984-09-17 Tokyo Tanabe Co Ltd サ−フアクタント及びそれを含有する呼吸窮迫症候群治療剤
CS938384A1 (en) * 1983-12-08 1990-08-14 Lachmann Burkhardt Pharmaceutical agent for breathlesness therapy and method of its production
IT1203873B (it) * 1987-04-08 1989-02-23 Chiesi Farma Spa Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e

Also Published As

Publication number Publication date
CA2020209C (en) 2000-09-12
KR0162642B1 (ko) 1998-12-01
FI95655B (fi) 1995-11-30
IE68448B1 (en) 1996-06-26
HK1000277A1 (en) 1998-02-20
NZ234341A (en) 1992-07-28
DE59009113D1 (de) 1995-06-29
EP0406732B1 (de) 1995-05-24
DD297916A5 (de) 1992-01-30
ATE122891T1 (de) 1995-06-15
KR910002427A (ko) 1991-02-25
NO902961L (no) 1991-01-07
NO180620B (no) 1997-02-10
CA2020209A1 (en) 1991-01-05
PT94574B (pt) 1997-02-28
PT94574A (pt) 1991-03-20
FI95655C (fi) 1996-03-11
NO902961D0 (no) 1990-07-03
AU623538B2 (en) 1992-05-14
ZA905182B (en) 1992-03-25
NZ242869A (en) 1997-05-26
JP3103582B2 (ja) 2000-10-30
PL164434B1 (pl) 1994-07-29
AU5867690A (en) 1991-01-10
IE902408A1 (en) 1991-06-19
PH30232A (en) 1997-02-05
US5552161A (en) 1996-09-03
HU205004B (en) 1992-03-30
DE3921954A1 (de) 1991-01-17
EP0406732A3 (en) 1991-02-27
HU904077D0 (en) 1990-12-28
IL94961A0 (en) 1991-06-10
UA26313A (uk) 1999-08-30
RU2077880C1 (ru) 1997-04-27
ES2072940T3 (es) 1995-08-01
JPH0344332A (ja) 1991-02-26
FI903341A0 (fi) 1990-07-03
IL94961A (en) 1994-10-21
HUT56274A (en) 1991-08-28
DK0406732T3 (da) 1995-10-02
EP0406732A2 (de) 1991-01-09

Similar Documents

Publication Publication Date Title
EP0406998A3 (en) Use of phospholipids in lung surfactant replacement therapy
BR9808812A (pt) Composição compreendendo partìculas cristalinas, finamente divididas de budesonida
NO180620C (no) Fremgangsmåte for fremstilling av surfaktantsuspensjoner for substitusjonsterapi ved luftveissykdommer
PH21102A (en) Improvements in or relating to benzothiophene derivatives as antiastmatic agents
FR2625679B1 (fr) Preparation aqueuse a base de sels mineraux et d'acide acetique pour la prevention et le traitement des maladies virales
GB2122486B (en) Agent for treating diseases or respiratory organs
GR3006674T3 (no)
PT86859A (pt) Process for the preparation of 9-ethyl-6,9-di-hydro-4,6-dioxo-10-propyl-4h-pyrano]3,2-g"-quinoline-2,8-calcium dicarboxilate and of pharmaceutical compounds containing it
ATE86112T1 (de) Pharmazeutische zubereitung zur behandlung entzuendeter nasenschleimhaeute.
FR2626884B1 (fr) Procede de preparation de n-phosphonomethyl-imino-diacetique et de chlorure d'acide en resultant
CS22891A2 (en) Application of benzylphosphonic acid's derivatives for treatment of virusinduced diseases
CS275046B2 (en) Method of sodium silicate's solution production
FI952953L (fi) Aineita metabolisten luustosairauksien hoitamiseen
EP0755262A4 (en) PNEUMOPATHY TREATMENT COMPOSITION
ATE147978T1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
AU5702890A (en) Therapeutic agents of metabolic bone disease
IL65774A (en) Citrate of naphthylhydrofuryl and pharmaceutical compositions containing it
GB8922012D0 (en) Composition for treatment of respiratory ailments
HU9802142D0 (en) Use of na+/h+ -ion-exchange inhibitors for producing pharmaceutical compositions for treating and profilacting diseases of the central nerve system
FR2644345B1 (fr) Composition therapeutique et coffret pour le traitement de la polyarthrite rhumatoide
GB2228399B (en) Process for enhancing the perceived strength of tobacco smoke
FR2628322B1 (fr) Nouvelles utilisations therapeutiques de l'acide 4-(3-phosphono-2-propenyl)-piperazine-2-carboxylique
IT1223461B (it) Procedimento per ottenere dei solfatati alcalini del destrano e dell'idrodestrano sostanzialmente esenti da ioni solfato e cloruro
PT94432A (pt) Processo para a producao sulfonamidas substituidas e compostos afins uteis no tratamento da asma, artrite e doencas afins
GB9025154D0 (en) Treatment of lung diseases